FCC Authority to Act as Agent Letter

File Info : application/pdf, 1 Pages, 22.88KB

Array
(
    [0] => Array
        (
            [url_sha] => 3fc18dc1945c42cb4c3e019fabd6a9900f1e618d87a63f70d55f6b0a57c4907d
            [source] => fccid
            [url] => https://apps.fcc.gov/eas/GetApplicationAttachment.html?id=4586399
            [href_text] => FCC Authority to Act as Agent Letter
            [href_description] => EPS Bio Technology Corp. D062 EasyMax Tag Self-Monitoring Blood Glucose System 2AQBR-D062 2AQBRD062 d062
            [http_status] => 200
            [http_lastmod] => 0000-00-00 00:00:00
            [http_contenttype] => application/pdf
            [http_filename] => GetApplicationAttachment.html?id=4586399
            [http_size] => 23432
            [file_sha256] => 1898c3e1a33f99b2f4bc767497a8905bec966a1eb61b3efe657a5def6b981c11
            [domain] => document.fccid
        )

)

Array
(
    [0] => Array
        (
            [id] => 4586399
            [file_sha256] => 
            [applicationId] => edkTB/0KMbFH8uoYSto+gA==
            [description] => FCC Authority to Act as Agent Letter
            [shortTermConfidential] => No
            [permanentConfidential] => No
            [supercede] => No
            [exhibitType] => Cover Letter(s)
            [fileType] => Adobe Acrobat PDF
            [displayType] => pdf
            [fileSize] => 23433
            [submissionDate] => 2020-01-13 00:00:00
            [dateAvailable] => 2020-01-20 00:00:00
            [creationDate] => 
            [producer] => 
            [modDate] => 
            [title] => 
            [creator] => 
            [author] => 
            [pages] => 
            [realSize] => 
            [html] => 0
            [png] => 0
            [txt] => 0
            [version] => 0
            [source] => 0
            [fccId] => 2AQBR-D062
            [cleanFccId] => 2AQBRD062
            [exif] => 0
        )

)